PETERSON KATHARINE (Chief Accounting Officer) sold 0.6% of their position (101.00 shares) of ACRIVON THERAPEUTICS, INC. on the open market
Open‑market sale worth $203.01 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/20/2026ACC: 0000905148-26-003840
Officer· Chief Accounting Officer
Since Mar 2026
-101.00
Net shares
Net seller
$203.01
Total sold
1
Open market trades
0B · 1S
1
Total transactions
101.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−101.00
Price / share
$2.01
Trade value
$203.01
% of position
0.6%
8/18/2026
18.13K→18.03K
Total
Net shares
−101.00
Net value
-$203.01
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | S · Sale | −101.00 | $2.01 | $203.01 | 0.6% | 18.13K | 18.03K |
| Total | −101.00 | -$203.01 | ||||||
Derivative Transactions0
No derivative transactions reported